PHAR vs PHARM: Side-by-Side Comparison
Compare Pharming Group N.V. (PHAR) and Pharming Group NV (PHARM) side by side: market cap USD 965.83M vs EUR 829.85M, P/E 79.9 vs 83.0. Financials, growth and model signals on Bullrun.
| Metric | PHAR | PHARM |
|---|---|---|
| Company | Pharming Group N.V. | Pharming Group NV |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · AS |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 965.83M | EUR 829.85M |
| P/E ratio | 79.9 | 83.0 |
| Dividend yield | — | — |
| Valuation model | 37.6% overvalued | 48.1% overvalued |
| Revenue (latest FY) | — | USD 376.13M |
| Revenue growth YoY | — | +26.6% |
| Net income | — | USD 2.54M |
| Gross margin | — | 87.9% |
| Diluted EPS | — | 0.00 |